Delivery Order SPE2DB20D1109-SPE2DB25FP50S
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on July 21, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa (abiraterone acetate) is a specialized pharmaceutical used in the treatment of prostate cancer, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of YONSA 125 mg tablets (120-count units) at a ceiling value of $4,542.74. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. YONSA is a prescription medication used in oncology treatment, reflecting the broad pharmaceutical portfolio...
- The Defense Logistics Agency awarded a $2,271.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of YONSA 125 mg, a prescription medication used in oncology treatment. This non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,195.48 firm fixed-price contract is for the supply of 4,565,190,069 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The delivery order is placed against a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for the provision of a comprehensive range of medical commodities to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,195.48 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564731145 - YONSA 125 MG TABLET 120S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, AmerisourceBergen provides a comprehensive range of...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $2,195.48 to supply 120 tablets of the brand name medication Yonsa 125 mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by December 28, 2023. No set-aside designation was applied to this award made against an existing indefinite-delivery contract between Amerisourcebergen...
- The Defense Logistics Agency awarded a $6,586 delivery order to Amerisourcebergen Drug Corporation for the supply of 120 bottles of 125mg Yonsa tablets. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location to support DLA requirements. Amerisourcebergen will deliver the pharmaceutical products under the terms of the contract by September 29, 2023 to meet Defense Department needs. No set aside designation or subcontracting arrangements were...
- This is a $2,271.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a period of performance through July 2025. The award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This $4,390.96 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for YONSA 125 MG TABLET 120S, a prescription drug product, with an ultimate completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP50SDelivery Order
The Defense Logistics Agency awarded a $4,542.74 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of 120 tablets of Yonsa 125 mg, with performance completion targeted for August 22, 2025. This firm fixed-price contract was awarded without set-aside designation through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa is a prescription medication used in oncology treatment, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its capability to meet federal medical supply requirements as a major pharmaceutical distributor serving the Department of Defense medical supply chain.